LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 2780

Search options

  1. Book: Dang dai ming lao Zhong yi feng cai

    Wang, Qin / Zhu, Jianping

    1999  

    Title variant Photograph album of veteran TCM doctors
    Author's details gu wen Li Zhenji ; bian zhu Wang Qin, Zhu Jianping
    MeSH term(s) Medicine, Chinese Traditional ; Physicians
    Keywords China
    Language Chinese
    Size 10, 252 p. :, ports ;, 30 cm.
    Edition Di 1 ban.
    Publisher Zhong yi gu ji chu ban she
    Publishing place Beijing Shi
    Document type Book
    Note "Guo jia que ren di yi pi shi dai tu zhuan jia hua ce".
    ISBN 9787800138812 ; 780013881X
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  2. Article ; Online: The era of SARS-CoV-2 variants calls for an urgent strategy for COVID-19 vaccination in children.

    Li, Si-Min / Zhu, Feng-Cai

    The Lancet. Infectious diseases

    2024  

    Language English
    Publishing date 2024-03-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(24)00157-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2.

    Li, Jing-Xin / Zhu, Feng-Cai

    The Lancet. Infectious diseases

    2022  Volume 22, Issue 7, Page(s) 916–917

    MeSH term(s) COVID-19/prevention & control ; COVID-19 Vaccines ; Humans ; Neutralization Tests ; Reinfection/prevention & control ; SARS-CoV-2/genetics ; Vaccines, Subunit
    Chemical Substances COVID-19 Vaccines ; Vaccines, Subunit
    Language English
    Publishing date 2022-04-18
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(22)00162-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease.

    Gao, Xing-Su / Zhu, Feng-Cai

    The Lancet. Rheumatology

    2021  Volume 4, Issue 2, Page(s) e77–e78

    Language English
    Publishing date 2021-12-03
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(21)00392-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Adjuvantation helps to optimise COVID-19 vaccine candidate.

    Li, Jing-Xin / Zhu, Feng-Cai

    The Lancet. Infectious diseases

    2021  Volume 21, Issue 7, Page(s) 891–893

    MeSH term(s) Adjuvants, Immunologic ; COVID-19 ; COVID-19 Vaccines ; Humans ; SARS-CoV-2
    Chemical Substances Adjuvants, Immunologic ; COVID-19 Vaccines
    Language English
    Publishing date 2021-03-08
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(21)00094-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.

    Li, Jing-Xin / Zhu, Feng-Cai

    Lancet (London, England)

    2021  Volume 398, Issue 10317, Page(s) 2134–2135

    MeSH term(s) Antibodies, Neutralizing ; COVID-19 ; COVID-19 Vaccines ; Humans ; SARS-CoV-2 ; Vaccines, Inactivated
    Chemical Substances Antibodies, Neutralizing ; COVID-19 Vaccines ; Vaccines, Inactivated
    Language English
    Publishing date 2021-11-11
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(21)02014-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Challenges in the Development of a Vaccine Against COVID-19.

    Chen, Wei / Zhu, Feng-Cai

    Engineering (Beijing, China)

    2020  Volume 6, Issue 10, Page(s) 1067–1069

    Keywords covid19
    Language English
    Publishing date 2020-09-14
    Publishing country China
    Document type Journal Article
    ZDB-ID 2886869-9
    ISSN 2095-8099
    ISSN 2095-8099
    DOI 10.1016/j.eng.2020.08.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Influenza surveillance in China: a big jump, but further to go.

    Huo, Xiang / Zhu, Feng-Cai

    The Lancet. Public health

    2019  Volume 4, Issue 9, Page(s) e436–e437

    MeSH term(s) China ; Disease Outbreaks ; Humans ; Influenza, Human/epidemiology
    Language English
    Publishing date 2019-09-02
    Publishing country England
    Document type Journal Article ; Comment
    ISSN 2468-2667
    ISSN (online) 2468-2667
    DOI 10.1016/S2468-2667(19)30158-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines.

    Jiang, Hu-Dachuan / Zhang, Li / Li, Jing-Xin / Zhu, Feng-Cai

    Engineering (Beijing, China)

    2021  Volume 7, Issue 7, Page(s) 903–907

    Language English
    Publishing date 2021-05-19
    Publishing country China
    Document type Journal Article
    ZDB-ID 2886869-9
    ISSN 2095-8099
    ISSN 2095-8099
    DOI 10.1016/j.eng.2021.04.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov.

    Wang, Shen-Yu / Liu, Wen-Qing / Li, Yu-Qing / Li, Jing-Xin / Zhu, Feng-Cai

    Expert review of vaccines

    2023  Volume 22, Issue 1, Page(s) 704–713

    Abstract: Introduction: The global spread of COVID-19 has prompted the development of vaccines. A recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV) developed by Chinese scientists has been authorized for use as a prime and booster dose in China ... ...

    Abstract Introduction: The global spread of COVID-19 has prompted the development of vaccines. A recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV) developed by Chinese scientists has been authorized for use as a prime and booster dose in China and several other countries.
    Areas covered: We searched published articles as of 4 May 2023, on PubMed using keywords related to Adenovirus vector, vaccine, and SARS-CoV-2. We reported the progress and outcomes of Ad5-nCov, including vaccine efficacy, safety, immunogenicity based on pre-clinical trials, clinical trials, and real-world studies for primary and booster doses.
    Expert opinion: Ad5-nCoV is a significant advancement in Chinese vaccine development technology. Evidence from clinical trials and real-world studies has demonstrated well-tolerated, highly immunogenic, and efficacy of Ad5-nCoV in preventing severe/critical COVID-19. Aerosolized Ad5-nCoV, given via a novel route, could elicit mucosal immunity and improve the vaccine efficacy, enhance the production capacity and availability, and reduce the potential negative impact of preexisting antibodies. However, additional research is necessary to evaluate the long-term safety and immunogenicity of Ad5-nCoV, its efficacy against emerging variants, its effectiveness in a real-world context of hybrid immunity, and its cost-effectiveness, particularly with respect to aerosolized Ad5-nCoV.
    MeSH term(s) Humans ; COVID-19 Vaccines/adverse effects ; COVID-19/prevention & control ; SARS-CoV-2 ; Antibody Formation ; Adenoviridae/genetics ; Antibodies, Viral ; Immunogenicity, Vaccine ; Antibodies, Neutralizing
    Chemical Substances COVID-19 Vaccines ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-07-27
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2181284-6
    ISSN 1744-8395 ; 1476-0584
    ISSN (online) 1744-8395
    ISSN 1476-0584
    DOI 10.1080/14760584.2023.2242528
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top